Study suggests increased number of heart attacks, strokes among Xolair users.
FDA says results are from observational study, not a randomized trial.
FDA is not advising asthma patients who use Xolair to stop.
Drug is used by up to 35,000 patients with moderate to severe persistent asthma.
